# NUVASIVE INC

NUVASIVE INC is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** NUVASIVE INC
- **Classification:** Company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001142596

## About

NUVASIVE INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001142596, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2023-02-22, it reported annual revenue of USD 1,201,942,000; net income of USD 40,407,000; total assets of USD 2,224,505,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $1.2B (USD 1,201,942,000)
- **Net income:** $40.4M (USD 40,407,000)
- **Total assets:** $2.2B (USD 2,224,505,000)
- **Cash and equivalents:** $248.7M (USD 248,663,000)
- **Operating cash flow:** $169.1M (USD 169,118,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $1.1B (USD 1,138,988,000)
- **Net income:** -$64.1M (USD -64,086,000)
- **Total assets:** $2.2B (USD 2,154,075,000)
- **Cash and equivalents:** $246.1M (USD 246,091,000)
- **Operating cash flow:** $182.2M (USD 182,174,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $1.1B (USD 1,050,582,000)
- **Net income:** -$37.2M (USD -37,153,000)
- **Total assets:** $2.7B (USD 2,693,082,000)
- **Cash and equivalents:** $856.9M (USD 856,869,000)
- **Operating cash flow:** $185.9M (USD 185,911,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $1.2B (USD 1,168,070,000)
- **Net income:** $65.2M (USD 65,234,000)
- **Total assets:** $1.9B (USD 1,885,290,000)
- **Cash and equivalents:** $213.0M (USD 213,034,000)
- **Operating cash flow:** $235.3M (USD 235,290,000)

## Recent SEC filings

- Form 8-K — filed 2023-09-01 — period 2023-09-01 — 8-K
- Form 10-Q — filed 2023-08-02 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-08-02 — period 2023-08-02 — 8-K
- Form 8-K — filed 2023-06-09 — period 2023-06-09 — 8-K
- Form 8-K — filed 2023-06-02 — period 2023-06-01 — 8-K
- Form 8-K — filed 2023-05-26 — period 2023-05-26 — 8-K
- Form 10-Q — filed 2023-05-10 — period 2023-03-31 — 10-Q
- Form 8-K — filed 2023-05-10 — period 2023-05-08 — 8-K
- Form DEF 14A — filed 2023-05-08 — DEF 14A
- Form 8-K — filed 2023-05-03 — period 2023-05-03 — 8-K
- Form 8-K — filed 2023-04-27 — period 2023-04-27 — 8-K
- Form 8-K — filed 2023-04-17 — period 2023-04-17 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/nuvasive-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology